DMARD is a term that is used interchangeably with second-line medications, slow-acting antirheumatic drugs, or disease-controlling antirheumatic therapy. The
by SS Zhao 2024 Cited by 17rheumatoid arthritis; antirheumatic drugs, disease-modifying; antirheumatic agents; biological products; rheumatology; treatment outcome
disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum
These compounds, called disease-modifying antirheumatic drugs (DMARDs) or slow-acting antirheumatic drugs (SAARDs), currently include MTX, the antimalarials
Drugs currently authorised as of December 2024 for use in psoriatic arthritis. bDMARD, biological disease-modifying antirheumatic drug; csDMARD, conventional synthetic disease-modifying antirheumatic drug; DMARD, disease-modifying antirheumatic drug; IL, interleukin; JAK, Janus kinase; PDE4, phosphodiesterase
These compounds, called disease-modifying antirheumatic drugs (DMARDs) or slow-acting antirheumatic drugs (SAARDs), currently include MTX, the antimalarials
disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum
Drug Classes Miscellaneous Agents; Antirheumatics. Antirheumatics. What are Antirheumatics? Antirheumatics include drugs, which are used to treat the symptoms
These compounds, called disease-modifying antirheumatic drugs (DMARDs) or slow-acting antirheumatic drugs (SAARDs), currently include MTX, the antimalarials
Comments